Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-218890
Filing Date
2012-05-08
Accepted
2012-05-08 17:15:22
Documents
9
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d314441d10q.htm 10-Q 456672
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 d314441dex311.htm EX-31.1 9897
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECION 302 d314441dex312.htm EX-31.2 9787
4 CERTIFICATIONS OF THE CEO AND THE CFO PURSUANT TO 18 U.S.C. SECTION 1350 d314441dex321.htm EX-32.1 4327
  Complete submission text file 0001193125-12-218890.txt   1666245

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptie-20120331.xml EX-101.INS 206793
6 XBRL TAXONOMY EXTENSION SCHEMA ptie-20120331.xsd EX-101.SCH 9001
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptie-20120331_cal.xml EX-101.CAL 26809
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptie-20120331_lab.xml EX-101.LAB 90879
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptie-20120331_pre.xml EX-101.PRE 57450
Mailing Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404
Business Address 2211 BRIDGEPOINTE PARKWAY SUITE 500 SAN MATEO CA 94404 6506248200
PAIN THERAPEUTICS INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 12822453
SIC: 2834 Pharmaceutical Preparations